You just read:

Oramed to Announce Results of its Phase 2a Clinical Trial for Oral Insulin on January 30th at the Tel Aviv Stock Exchange

News provided by

Oramed Pharmaceuticals Inc.

Jan 27, 2014, 09:10 EST